Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacoscintigraphic study of biphasic sildenafil (N4S001)
NCT03510338Phase 1Completed
- Sponsor
- N4 Pharma
- Start
- May 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ASP-001 in erectile dysfunction (ED) (4 arms), sponsored by N4 Pharma. Primary endpoint: Sildenafil plasma concentrations at 24 hours. Started May 2018; status: completed.
02
Drugs
ASP-001
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT03510338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03510338.